Tatva Chintan Pharma Chem Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 17, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	27,930	24,618	15,840	25,231	36,995	51,166
Market Cap Growth	32.21%	55.42%	-37.22%	-31.80%	-27.70%	-
Enterprise Value	29,046	25,276	15,844	24,403	37,505	50,113
Last Close Price	1195.00	1050.90	678.28	1076.27	1659.80	2296.05
PE Ratio	66.41	58.54	277.26	83.12	81.33	53.37
PS Ratio	5.52	4.87	4.14	6.41	8.73	11.80
PB Ratio	3.57	3.15	2.14	3.42	7.19	10.82
P/TBV Ratio	3.60	3.18	2.16	3.44	7.19	10.82
P/OCF Ratio	88.70	78.18	64.21	25.73	133.16	252.92
EV/Sales Ratio	5.74	5.00	4.14	6.20	8.85	11.56
EV/EBITDA Ratio	31.18	27.13	47.71	35.40	55.46	46.26
EV/EBIT Ratio	51.58	44.89	237.11	55.74	64.15	49.87
Debt / Equity Ratio	0.15	0.15	0.05	0.02	0.33	0.25
Debt / EBITDA Ratio	1.29	1.29	1.09	0.21	2.51	1.10
Net Debt / Equity Ratio	0.14	0.14	0.03	-0.04	0.25	0.12
Net Debt / EBITDA Ratio	1.20	1.20	0.74	-0.45	1.91	0.52
Net Debt / FCF Ratio	-1.36	-1.36	-0.48	1.03	-0.74	-0.81
Asset Turnover	0.55	0.55	0.46	0.50	0.60	0.89
Inventory Turnover	1.36	1.36	1.44	1.16	1.40	1.67
Quick Ratio	0.60	0.60	1.07	1.48	0.54	0.73
Current Ratio	1.64	1.64	2.76	3.74	1.31	2.55
Return on Equity (ROE)	5.53%	5.53%	0.77%	4.85%	9.21%	30.00%
Return on Assets (ROA)	3.82%	3.82%	0.51%	3.47%	5.16%	12.91%
Return on Invested Capital (ROIC)	4.85%	5.01%	0.69%	4.52%	9.97%	23.72%
Return on Capital Employed (ROCE)	7.10%	7.10%	0.90%	5.90%	11.20%	20.60%
Earnings Yield	1.51%	1.71%	0.36%	1.20%	1.23%	1.87%
FCF Yield	-2.95%	-3.34%	-3.26%	-1.21%	-4.74%	-1.35%
Dividend Yield	0.08%	0.19%	0.15%	0.19%	0.12%	0.09%
Payout Ratio	5.56%	5.56%	81.88%	15.41%	9.75%	-
Buyback Yield / Dilution	0.01%	0.01%	-2.20%	-3.27%	-3.10%	-7.03%
Total Shareholder Return	0.10%	0.20%	-2.05%	-3.08%	-2.98%	-6.94%